AstraZeneca PLC
AZNCF · PINK142.50
142.50
USD1.000.71%Fecha
Tickers
Titular
Fuente
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year. https://t.co/b5hOwTxWaU https://t.co/Wq5EsZGLK5
AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition
SeekingAlpha
FibroGen sells China unit to AstraZeneca for $160 million
SeekingAlpha
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
CNBC
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
MarketWatch
AstraZeneca to pay up to $2 billion to license cardiovascular drug
MarketWatch
Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030
CNBC
AstraZeneca completes acquisition of Fusion Pharmaceuticals
SeekingAlpha
Ontario court approves AstraZeneca/Fusion acquisition plan
SeekingAlpha
Fusion shareholders give green light to AstraZeneca acquisition
SeekingAlpha
AstraZeneca to build $1.5 billion cancer drug manufacturing plant in Singapore - Reuters
Reuters
AstraZeneca will buy Fusion Pharmaceuticals for ~$2B
SeekingAlpha
AstraZeneca to expand rare disease pipeline with $1.05B Amolyt Pharma acquisition
SeekingAlpha
Gracell Biotechnologies receives shareholder approval for merger with AstraZeneca
SeekingAlpha
Icosavax ticks lower as HSR filing for AstraZeneca deal withdrawn, refiled
SeekingAlpha
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK
MarketWatch
AstraZeneca to buy Gracell Biotechnologies for $1.2 billion
SeekingAlpha
Ionis Pharmaceuticals, AstraZeneca get FDA approval for rare genetic disease treatment
MarketWatch
Cytokinetics gains amid report of Novartis, AstraZeneca takeover interest
SeekingAlpha
AstraZeneca to acquire vaccine maker Icosavax in ~$1.1B deal
SeekingAlpha
Icosavax enters agreement to be acquired by Astrazeneca
SeekingAlpha
AstraZeneca partners with AI company to find cure for cancer
CoinTelegraph
AstraZeneca and Absci Collaborate on AI-Driven Cancer Therapy Development
Cryptopolitan
Drug Giant AstraZeneca Launches Evinova to Quicken Clinical Trials
Decrypt
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
CNBC
AstraZeneca adds player to obesity drug race, but Eli Lilly remains in the lead
CNBC
AstraZeneca hikes earnings forecast as surging cancer drug sales offset plunging revenue from COVID vaccines
MarketWatch
Nanoform Grants AstraZeneca Global STARMAP AI License for Innovative Nanoparticle Medicine Development
Cryptopolitan
As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment
MarketWatch
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
CNBC
Stocks making the biggest moves in premarket trading: AstraZeneca, Paramount, Nike and more
CNBC
Stocks making the biggest moves premarket: AstraZeneca, Wayfair, Alibaba and more
CNBC
AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies
MarketWatch
AstraZeneca shares slump after Phase 3 lung cancer drug study
MarketWatch
Movers & Shakers: Tesla shares rally on delivery numbers, AstraZeneca stock slumps on drug trial, and other stocks on the move
MarketWatch
AstraZeneca to decarbonize U.S. footprint by turning cow manure into renewable natural gas
MarketWatch
FDA advisors recommend AstraZeneca antibody to protect babies from RSV
CNBC
AstraZeneca's Tagrisso slashes death risk in certain post-surgery lung cancer patients - Reuters
Reuters
Preguntas Frecuentes
¿A qué estás esperando?Comienza a obtener beneficios hoy
Herramientas
Mercados
Más
Recursos
Comparar
Aplicación móvil de beneficios
Descubre el mundo de las finanzas en tu bolsillo
©
2025
Todos los derechos reservados